BioSpace News Archive

Business

Sage Therapeutics Announces Third Quarter 2017 Financial Results and Provides Pipeline Update

Sage will host a conference call and webcast today at 8:00 AM ET to discuss its third quarter financial results and recent corporate updates.

November 2, 2017
·
14 min read
Business

Evotec AG to Report First Nine-Month 2017 Results on 08 November 2017

Evotec will report its financial results for the first nine months of 2017 on Wednesday, 08 November 2017.

November 2, 2017
·
3 min read
Business

AmerisourceBergen Reports Fiscal 2017 Fourth Quarter and Year End Results

AmerisourceBergen reported that in its fiscal year 2017 fourth quarter ended September 30, 2017, revenue increased 4.2 percent to $39.1 billion.

November 2, 2017
·
45 min read
Business

Natera Announces Third Quarter 2017 Earnings Conference Call

Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities and financial outlook.

November 2, 2017
·
2 min read
Business

BD Announces Results For 2017 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2018 Guidance

On a comparable, currency-neutral basis, fourth quarter revenues grew 4.4 percent, which includes an estimated 100 basis point adverse impact from the previously disclosed change in the U.S. dispensing business model.

November 2, 2017
·
79 min read
Bio NC

Male Contraception Initiative Awards $500K Research Grant to Vibliome Therapeutics, Inc., for the Development of a New Contraceptive Product

The project will focus on the development of a Vibliome drug candidate that is a highly selective inhibitor of homeodomain-interacting protein kinase 4 (HIPK4).

November 2, 2017
·
2 min read
Business

Teleflex Reports Third Quarter 2017 Results

Third quarter 2017 net revenues were $534.7 million, an increase of 17.4% compared to the prior year period.

November 2, 2017
·
35 min read
Business

DowDuPont Reports Third Quarter 2017 Results

DowDuPont reported GAAP diluted earnings1 per share of $0.32. Pro forma adjusted earnings2 per share of $0.55 increased 10 percent compared to the year-ago period.

November 2, 2017
·
60 min read
Medtronic Evolut PRO TAVR System With Advanced Sealing Maintains Excellent Outcomes Over Time

Six-month data from the newest-generation Evolut PRO System demonstrated continued benefits of its unique valve design.

November 2, 2017
·
3 min read
Business

PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Translarna net product sales were $32.0 million for the third quarter of 2017, representing 45% growth over $22.0 million reported in the third quarter of 2016.

November 2, 2017
·
26 min read